Tailored Genes develops tailored lentivirus vectors for delivering precise therapeutic genes to target cells.
Tailored Genes has raised $1.0M in total funding. The most recent round was Grant. The last funding was announced in October 2025.
Tailored Genes's investors include FedDev.
Tailored Genes is headquartered in Toronto, Canada.
Tailored Genes develops tailored lentivirus vectors for delivering precise therapeutic genes to target cells.
Tailored Genes is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Tailored Genes — Funding & Investors." VCBacked, October 16, 2025, https://www.vcbacked.co/company/tailored-genes. Accessed October 6, 2026.
VCBacked. (2025). Tailored Genes — Funding & Investors. Retrieved October 6, 2026, from https://www.vcbacked.co/company/tailored-genes
{{cite web |title=Tailored Genes — Funding & Investors |url=https://www.vcbacked.co/company/tailored-genes |website=VCBacked |access-date=October 6, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated